Aller au contenu principal
Profil bibliographique

Morena Giovannelli

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées
525Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Neurological disorders and treatmentsBotulinum Toxin and Related Neurological DisordersParkinson's Disease Mechanisms and TreatmentsMultiple Sclerosis Research StudiesTranscranial Magnetic Stimulation Studies

Les publications récentes

Accès ouvert 2026 review OpenAlex

Effects of Continuous Infusion Therapies on Non-Motor Symptoms in Advanced Parkinson’s Disease: A Systematic Review

Domiziana Rinaldi, Lanfranco De Carolis, Claudia Ledda, S. Galli et autres

Background/Objectives: Non-motor symptoms (NMS) are highly prevalent in advanced Parkinson’s disease (PD) and substantially affect quality of life. Continuous infusion therapies are established treatment options for motor fluctuations not controlled by oral medication, but their effects on NMS remain incompletely characterized. We …

it (code pays fourni par la source)

0 citations Brain Sciences
Accès ouvert 2025 article OpenAlex

Unraveling gait and balance impairment in cervical dystonia: associated features, functional implications, and the effect of botulinum toxin

S. Galli, Claudia Ledda, Silvia Gallo, Maurizio Zibetti et autres

BACKGROUND: Cervical dystonia (CD) may affect not only head posture but also gait and balance. The relationship between quantitative gait abnormalities and perceived disability, the contribution of head tremor (HT) and the impact of botulinum toxin (BoNT) on these disturbances remain unclear. …

it (code pays fourni par la source)

0 citations Parkinsonism & Related Disorders
Accès ouvert 2025 article OpenAlex

Spasticity Management with Botulinum Toxin in Post-stroke and Multiple Sclerosis Patients: A Retrospective, ‘Real-world’, Multicenter Study

Calogera Butera, Marcello Esposito, Assunta Trinchillo, Morena Giovannelli et autres

Background While there is strong evidence for botulinum toxin-A (BoNT-A) in post-stroke spasticity, there is a paucity of data in multiple sclerosis and other conditions in real-world settings. Objective Document the use of BoNT-A in the management of spasticity, with focus on …

it, fr (code pays fourni par la source)

2 citations Neurorehabilitation
Accès ouvert 2024 article OpenAlex

Comprehensive Observational and Longitudinal study on the Outbreak of Stroke-related Spasticity focusing on the Early Onset management with Botulinum NeuroToxin (COLOSSEO-BoNT): protocol for a real-world prospective observational study on upper limb spasticity

Massimo Marano, Antonio Suppa, Maria Giuseppina Palmieri, Emanuela Cecconi et autres

INTRODUCTION: Poststroke spasticity (PSS) affects up to 40% of patients who had a stroke. Botulinum neurotoxin type A (BoNT-A) has been shown to improve spasticity, but the optimal timing of its application remains unclear. While several predictors of upper limb PSS are …

it, us (code pays fourni par la source)

2 citations BMJ Open
Accès ouvert 2017 article OpenAlex

Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions

Pamela Latino, Stefania Tagliente, Clelia Pellicano, Morena Giovannelli et autres

Cognitive impairment is a frequent non-motorsymptom of Parkinson’s disease (PD). In early disease stage, this takes the features of dysexecutive syndrome, and is mostly dependent on derangement of frontostriatal circuitries. In advanced stages, worsening of dysexecutive symptoms is accompanied by disorientation and …

it (code pays fourni par la source)

1 citation Advances in Parkinson s Disease

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.